Literature DB >> 1762126

A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Biochemical genetics study.

C Satoh1.   

Abstract

After 40 years of studies on the children of atomic bomb survivors and a suitable control population in which no statistically significant genetic effects of A-bomb radiation were observed, two new projects have been initiated in order to detect mutations in the DNA and RNA molecules. Permanent cell lines from peripheral B-lymphocytes from approximately 500 families composed of exposed parents and their children and approximately 500 control families are being established by Epstein-Barr virus transformation. Cells will be sources for DNA and RNA samples in the screening for mutations. After comparison of efficiencies of the scanning techniques, we selected the denaturing gradient gel electrophoresis (DGGE) of DNA fragments amplified by polymerase chain reaction (PCR) for our purpose. A small scale pilot study has started to solve problems and obtain a better efficiency in this approach. Current thinking about the most efficient procedures is presented.

Entities:  

Mesh:

Year:  1991        PMID: 1762126     DOI: 10.1269/jrr.32.supplement_378

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  3 in total

1.  Variations among Japanese of the factor IX gene (F9) detected by PCR-denaturing gradient gel electrophoresis.

Authors:  C Satoh; N Takahashi; J Asakawa; K Hiyama; M Kodaira
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

2.  Lack of effects of atomic bomb radiation on genetic instability of tandem-repetitive elements in human germ cells.

Authors:  M Kodaira; C Satoh; K Hiyama; K Toyama
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

3.  Genetic analysis of children of atomic bomb survivors.

Authors:  C Satoh; N Takahashi; J Asakawa; M Kodaira; R Kuick; S M Hanash; J V Neel
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.